The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors

NCT05263986 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumor

Interventions

DRUG: MRTX849

Sponsor

Zai Lab (Shanghai) Co., Ltd.

Collaborators

[object Object]